The revisions to the USP <797> standards are now in effect as of November 1, 2023 for pharmacies that create Category 3 compounded sterile preparations. These pharmacies will need to adapt to achieve compliance with USP <797>, and doing so will require a great deal of time and expense. Thankfully, AIS is ready to meet these revised standards. Are you?
Click the link to learn more about how AIS meets or exceeds industry standards or contact us here. We’re here to help.
This post is related to:
IV/Infusion Resources/USP <797> Resources
